These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The esophagitis to adenocarcinoma sequence; the role of inflammation. Kavanagh ME; O'Sullivan KE; O'Hanlon C; O'Sullivan JN; Lysaght J; Reynolds JV Cancer Lett; 2014 Apr; 345(2):182-9. PubMed ID: 23994342 [TBL] [Abstract][Full Text] [Related]
5. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Fitzgerald RC; Onwuegbusi BA; Bajaj-Elliott M; Saeed IT; Burnham WR; Farthing MJ Gut; 2002 Apr; 50(4):451-9. PubMed ID: 11889061 [TBL] [Abstract][Full Text] [Related]
6. Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma. Kavanagh ME; Conroy MJ; Clarke NE; Gilmartin NT; Feighery R; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; O' Sullivan J; Lysaght J Cancer Microenviron; 2019 Apr; 12(1):57-66. PubMed ID: 30834503 [TBL] [Abstract][Full Text] [Related]
7. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA; Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305 [TBL] [Abstract][Full Text] [Related]
8. Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. O'Rorke MA; Cantwell MM; Abnet CC; Brockman AJ; Murray LJ; Int J Cancer; 2012 Oct; 131(8):1882-91. PubMed ID: 22262413 [TBL] [Abstract][Full Text] [Related]
9. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma. Salimian KJ; Birkness-Gartman J; Waters KM Pathology; 2022 Mar; 54(2):147-156. PubMed ID: 34711413 [TBL] [Abstract][Full Text] [Related]
10. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum. Royston C; Bardhan KD Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751 [TBL] [Abstract][Full Text] [Related]
11. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067 [TBL] [Abstract][Full Text] [Related]
12. [Reflux esophagitis, barrett esophagus and adenocarcinoma of the esophagus]. Pera C Rev Quir Esp; 1988; 15(3):115-6. PubMed ID: 3153375 [No Abstract] [Full Text] [Related]
13. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Denver P; Donnelly M; Murray LJ; Anderson LA World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165 [TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. Moons LM; Kusters JG; Bultman E; Kuipers EJ; van Dekken H; Tra WM; Kleinjan A; Kwekkeboom J; van Vliet AH; Siersema PD J Pathol; 2005 Nov; 207(3):269-76. PubMed ID: 16177953 [TBL] [Abstract][Full Text] [Related]
15. Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link? Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Hourigan CS; Dev Bardhan K Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):801-6. PubMed ID: 21701391 [TBL] [Abstract][Full Text] [Related]